Skip to main content

Main navigation

  • Expertise
  • Publications & Insights
  • People
  • Careers

Secondary navigation

  • Value added services
  • CSR
  • About us

SearchSearch results for: “”

107 results

Breaking news from the CJEU: no SPCs for new therapeutic applications

On 9 July 2020, the Grand Chamber of the CJEU ruled on the interpretation of Article 3(d) of Regulation 469/2009 concerning the supplementary protection certificate (CCP) for medicinal products.

Stibbe advises leading pharmaceutical company

Stibbe assisted a leading pharmaceutical company in identifying the most cost-effective way to obtain in Belgium an improved pricing and reimbursement for new fixed-dose combination products composed of off-patent ingredients.

Stibbe advises Canon

Advising Canon in connection with their dispute with the State of the Netherlands on the procurement of framework contracts. Case won up to and including the Supreme Court.

Stibbe advises Mylan

Stibbe advises global pharmaceutical company Mylan on the merger control aspects of its USD 7.2 billion acquisition of Swedish drugmaker Meda.

Stibbe advises Aedifica

Stibbe advises Aedifica, a Belgian listed company investing in health care real estate, on reaching agreement to acquire two new senior housing sites in Lochem and Rotterdam.

Stibbe advises Aedifica

Stibbe advises Aedifica, a Belgian listed company investing in health care real estate, on the acquisition of a new senior housing site in Arnhem.

This is the second investment of Aedifica in The Netherlands. Aedifica has developed a portfolio of health

Stibbe advises Sonova Holding AG

Stibbe has advised Sonova Holding AG on its acquisition of AudioNova B.V. from HAL Investments. The value of AudioNova is EUR 830 million.

Stibbe advises Aedifica

Stibbe advises Aedifica, a Belgian listed company investing in health care real estate, on its acquisition of four senior housing sites in The Netherlands.

Stibbe advises on the IPO of Ferrari

Stibbe advises UBS and the other underwriters on the IPO of Ferrari N.V.

Stibbe represents Mylan

On 27 July 2015, Teva Pharmaceutical Industries announced that it has withdrawn its previously announced hostile bid to acquire Mylan N.V. Stibbe represented Mylan in this successful takeover defence and advised Mylan on both litigation and EU competition

Stibbe advises Tribune Media Company

Advising Tribune Media Company and its subsidiary Gracenote, the world’s leading provider of entertainment data, on its acquisition of Infostrada Sports.

Stibbe advises Tornier

Stibbe advises Tornier N.V. on its merger with Wright Medical Group, Inc. in an all stock transaction with a combined equity value of approximately $3.3 billion.

Stibbe advises Mylan

Stibbe advises Mylan Inc., the pharmaceuticals company listed on the NASDAQ with a market cap of approximately $19 billion, on the inversion acquisition of Abbott’s non-U.S. developed markets specialty and branded generics business.

Stibbe advises KPS Capital Partners on the acquisition of Taylor Made Golf Company, Inc.

Stibbe advised KPS Capital Partners, LP on the USD 425 million acquisition of Taylor Made Golf Company, Inc. from adidas AG.

Stibbe represents VodafoneZiggo

Stibbe represented VodafoneZiggo in a dispute with Fox Sports concerning the length of the contracts and the level of fees Ziggo has to pay Fox for broadcasting the football channels in the Netherlands.

Stibbe advises Aedifica

Stibbe advised Aedifica recently on two transactions in order to further expand her Dutch portfolio of care assets.

Stibbe advises Aedifica

Stibbe advises Aedifica on the acquisition of a care residence that will be constructed in Leersum. Aedifica acquired the full property of the site from Woudenburcht B.V., a local real estate developer. See for the press release here.

Stibbe advises Tribune Media Company

Stibbe advises Tribune Media Company on the Dutch law aspects of the sale of its Gracenote division to Nielsen.

Pagination

  • Previous page
  • Page 3
  • Page 4
  • Current page 5
  • Page 6
  • Next page
Reset filters
Date
Content type
  • Article (22)
  • Event (2)
  • Inside Stibbe (1)
  • Matter (53)
  • Podcast (1)
  • People (28)
Expertise
  • (-) Healthcare and Life Sciences (85)
  • (-) Sports (27)
  • Audit Firms and Accountancy (76)
  • Banking and Finance (431)
  • Capital Markets (247)
  • Compliance, Sanctions and Risk (162)
  • Corporate and M&A (878)
  • Corporate Investigations (31)
  • Criminal Law and Enforcement (145)
  • Employment, Benefits and Pensions (418)
  • Energy, Industry and Climate (316)
  • Environment and Planning (894)
  • ESG & Sustainability (302)
  • EU and Competition Law (485)
  • Financial Regulation (173)
  • Infrastructure and Mobility (193)
  • Insurance (35)
  • Intellectual Property (120)
  • Investment Funds (142)
  • Litigation and Arbitration (428)
  • Mass Litigation (91)
  • Privacy and Data Protection (206)
  • Private Equity (198)
  • Procurement Law (123)
  • Public Law (1201)
  • Real Estate (473)
  • Restructuring and Insolvency (116)
  • Tax (452)
  • Tech (196)
  • Technology, Media and Telecommunications (335)
  • Unfair Competition and Consumer Protection (187)
Jurisdiction
  • BE Law (25)
  • EU Law (15)
  • LU Law (7)
  • NL Law (52)
Language
  • Dutch (9)
  • English (96)
  • French (2)

Footer main navigation

  • Expertise
  • Publications & Insights
  • People
  • Careers
© 2025 Stibbe

Footer navigation

  • Contact
  • Disclaimer
  • General Conditions
  • Register of legal practice areas
  • Privacy and Cookie Policy
  • Cookies Settings
  • Important Information